Circulating angiogenesis biomarkers are associated with disease progression in lung adenocarcinoma.
Circulating angiogenesis biomarkers are associated with disease progression in lung adenocarcinoma. Ann Thorac Surg. 2014 Dec; 98(6):1968-75; discussion 1975.